Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG

(EUZ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Eckert & Ziegler Receives Approval for Gallium-68 Generator for Brasil

11/18/2021 | 07:18am EST

Eckert & Ziegler Strahlen- und Medizintechnik AG received approval for its pharmaceutical Ge/Ga generator GalliaPharm from the Brazilian health authority ANVISA. GalliaPharm is thus the first and currently the only pharmaceutical gallium generator approved in Brazil. GalliaPharm is already successfully used in combination with approved kits, for the diagnosis of neuroendocrine tumors and in clinical trials also for prostate cancer. In Brazil, more than 590.000 new cases of cancer have been reported in 2020, with 97.278 in prostate, followed by breast and colorectum cancer. Gallium generators offer a low-cost alternative to radioactive labeling of biomolecules with gallium-68 in PET, an imaging examination method used to detect the presence or absence of diseased tissue. The procedure is used primarily in the diagnosis of cancer, heart attacks or neurological diseases. Up to now, the radioisotopes fluorine-18 or carbon-11 have mostly been used to label biomolecules. This requires millions of dollars of investment in large-scale equipment. The Ge/Ga generator, on the other hand, is about the size of a thermos flask and can be obtained much more cheaply, which reduces costs and increases flexibility in nuclear medical clinics and practices.


ę S&P Capital IQ 2021
All news about ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
01/11ECKERT & ZIEGLER STRAHLEN- UND MEDIZ : Notification and public disclosure of transactions ..
EQ
01/11Eckert & Ziegler Unit Enters Supply Deal for Ytterbium-176 Isotope with US Firm; Shares..
MT
01/10Eckert & Ziegler Signs Exclusive Supply Agreement for Ytterbium-176
EQ
01/03Eckert & Ziegler Buys Argentinian Nuclear Medicine Firm Tecnonuclear
MT
01/03???????Eckert & Ziegler Acquires Argentinian SPECT Specialist
EQ
01/03Eckert & Ziegler Strahlen- und Medizintechnik AG acquired Tecnonuclear S. A.
CI
2021Eckert & Ziegler Partners with University Health Network and CanProbe to Advance PENTIX..
EQ
2021ECKERT & ZIEGLER STRAHLEN UND MEDIZI : Declaration on the Corporate Governance Code 2021
PU
2021Eckert & Ziegler Receives Approval for Gallium-68 Generator for Brasil
EQ
2021Eckert & Ziegler Receives Approval for Gallium-68 Generator for Brasil
CI
More news
Analyst Recommendations on ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
More recommendations
Financials
Sales 2021 180 M 200 M 200 M
Net income 2021 26,9 M 30,0 M 30,0 M
Net cash 2021 96,9 M 108 M 108 M
P/E ratio 2021 56,6x
Yield 2021 0,59%
Capitalization 1 540 M 1 718 M 1 716 M
EV / Sales 2021 8,04x
EV / Sales 2022 6,29x
Nbr of Employees 841
Free-Float -
Chart ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
Duration : Period :
Eckert & Ziegler Strahlen- und Medizintechnik AG Technical Analysis Chart | EUZ | DE0005659700 | MarketScreener
Technical analysis trends ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 74,20 €
Average target price 172,00 €
Spread / Average Target 132%
EPS Revisions
Managers and Directors
Andreas Eckert Chairman-Executive Board
Wolfgang Maennig Chairman-Supervisory Board
Helmut Grothe Vice Chairman-Supervisory Board
Albert Rupprecht Member-Supervisory Board
Edgar L÷ffler Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG-21.15%1 753
JOHNSON & JOHNSON-1.57%443 277
ROCHE HOLDING AG-7.91%306 143
PFIZER, INC.-10.23%297 538
ABBVIE INC.-0.86%237 303
ELI LILLY AND COMPANY-13.89%215 642